Adma Biologics (ADMA ... Shares of the infectious disease drug developer witnessed a loss of 3.02% over the previous month, trailing the performance of the Medical sector with its gain of 5. ...

Adma Biologics (ADMA ... Prior to today's trading, shares of the infectious disease drug developer had lost 2.7% over the past month. This has lagged the Medical sector's gain of 3.73% and ...

Total Revenue of $426.5 Million, a 65% YoY IncreaseFY 2024 GAAP Net Income of $197.7 Million, Including an $84.3 Million Valuation ...

RAMSEY, N.J. (AP) — RAMSEY, N.J. (AP) — Adma Biologics Inc. (ADMA) on Monday reported fourth-quarter net income of $111.9 million, after reporting a loss in the same period a year earlier. The Ramsey, ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...

ADMA Biologics, Inc. ( NASDAQ: ADMA) Q4 2024 Earnings Conference Call March 3, 2025 4:30 PM ET Skyler Bloom - Senior Director, Business Development and Corporate Strategy Adam Grossman - Founder, ...

The infectious disease drug developer posted revenue of $117.5 ... Revenue was reported as $426.5 million. Adma Biologics shares have dropped nearly 8% since the beginning of the year.